Product Library
Browse pharmaceutical products with CDE, DMF, and CEP registrations
Total Products
6,983
CDE Registered
2,964
DMF Registered
4,212
CEP Registered
932
Products starting with "S"
582 total, page 26 of 30| Product | CAS | CDE | DMF | CEP | Pattern | Action |
|---|---|---|---|---|---|---|
| Simvastatin, Bha, Process II 辛伐他汀无润滑剂颗粒 | 79902-63-9 | 0 | 0 | 1 | CEP | View → |
| Sorafenib Tosilate, Micronised, Polymorphic Form I | 475207-59-1 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 2.3 M3/kg, By Fermentation, For Parenteral Administration Other Than Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Ha-ep 3.0 (intrinsic Viscosity: 2.7-3.6 M3/kg); From Fermentation; For Parenteral Administration Including Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Spectinomycin Dihydrochloride Pentahydrate, Jinxi pentahydrate | 22189-32-8 | 0 | 0 | 1 | CEP | View → |
| Spectinomycin Sulfate Tetrahydrate For Veterinary Use, Jinxi tetrahydrate | 64058-48-6 | 0 | 0 | 1 | CEP | View → |
| Simvastatin, With Butylated Hydroxyanisole 0.010% 辛伐他汀无润滑剂颗粒 | 79902-63-9 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 1.8 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 2.5 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Ha-e2.0 (intrinsic Viscosity 1.2-2.8 M3/kg), From Fermentation, For Parenteral Administration Other Than Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 2.4 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Ha-ep 1.8 (intrinsic Viscosity: 1.6-2.2 M3/kg); From Fermentation; For Parenteral Administration Including Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 0.6 M3/kg And 0.8 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 3.8 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 1.4 M3/kg And 1.0 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Simvastatin, Process II 辛伐他汀无润滑剂颗粒 | 79902-63-9 | 0 | 0 | 1 | CEP | View → |
| Simvastatin, Process II, With Butylated Hydroxyanisole 0.010% 辛伐他汀无润滑剂颗粒 | 79902-63-9 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 1.25 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 1.66 M3/kg, 2.27 M3/kg, 3.30 M3/kg; From Fermentation; For Parenteral Administration Including Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity: 2.93 M3/kg, From Fermentation, For Parenteral Administration, Including Intra-articular Administration, And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |